Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1

Interventions

Paclitaxel 2Carboplatin 2pembrolizumab 1iso-sulfan blue 1camrelizumab 1Watchful Waiting 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Adjuvant 1Positron Emission Tomography Computed Tomography 1Observation 1Nivolumab 1Magnetic Resonance Spectroscopy 1Immune Checkpoint Inhibitors 1Chemoradiotherapy 1Cetuximab 1Capecitabine 1Biopsy 1Aminolevulinic Acid 1(225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Mouth Neoplasms × Radiotherapy, Adjuvant × Clear all
NCT07457099 2026-03-09

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Zhujiang Hospital

Not yet recruiting
85 enrolled
Head & Neck

Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡